Editorial Staff

  • Executive Editor/VP-Special Projects:
    Jeff Hall
  • Senior Editor
    Brian McCurdy
  • Circulation and Subscriptions
    Bonnie Shannon
  • Art Director:
    Alana Balboni
  • Editorial Correspondence

  • Jeff Hall, Executive Editor/VP-Special Projects, Podiatry Today
  • HMP Communications, 83 General Warren Blvd
    Suite 100, Malvern PA 19355
  • Telephone: (800) 237-7285, ext. 214
    Fax: (610) 560-0501
  • Email: jhall@hmpcommunications.com
  • December 2004 | Volume 17 - Issue 12
    By Mark A. Caselli, DPM, and John Brummer, DPM
    35,657 reads | 0 comments | 12/03/04
       Fluid replacement is an important part of any athletic regimen, but proper hydration is one of the most neglected aspects of the athlete’s diet. Now that podiatrists are active members of the medical teams servicing many types of athletic events (and often act as medical directors and co-directors), it is vital to have a working knowledge of the signs and symptoms of dehydration. Active sports medicine podiatrists should also be able to develop a plan for establishing hydration protocols at sporting events.    When athletes engage in sport, they will lose ... continue reading
    By Brian McCurdy, Associate Editor
    6,743 reads | 0 comments | 12/03/04
       Methicillin resistant Staph aureus (MRSA) infections are on the rise around the world as infections pass between hospitals and the community. The infections are not only associated with morbidity and mortality but also pose a high financial cost to patients and the healthcare profession, according to experts. What is causing the rise in antibiotic resistance and what steps should DPMs take to prevent and combat infection?    The incidence of MRSA infection has increased 40 percent in five years and one-third of pneumonia among patients on ventilators ... continue reading
    By Allan B. Grossman, DPM and Matt Sowa, DPM
    48,506 reads | 0 comments | 12/03/04
       Venous thromboembolism (VTE) or deep vein thrombosis (DVT) is a common medical condition associated with considerable morbidity and mortality. Undiagnosed and untreated VTE can put patients at an unacceptable risk for a pulmonary embolism, which can be fatal. Thromboemboli account for 600,000 new cases, 300,000 admissions and approximately 100,000 deaths a year. Given that VTE has a recurrence rate of approximately 30 percent, early diagnosis and treatment are imperative.    In order to understand the risk factors of deep vein thrombosis (DVT), one must firs ... continue reading